Price cuts secure NHS place for MS drugs

14th May 2018 Uncategorised 0

NICE is now backing a trio of therapies to treat relapsing remitting forms of multiple sclerosis after price cuts enabled the cost regulator to endorse their routine use on the NHS.

More: Price cuts secure NHS place for MS drugs
Source: News